Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol. 2018;24(2):108-113.   Published online 2018 Jan 22     DOI: https://doi.org/10.3350/cmh.2017.0068
Citations to this article as recorded by Crossref logo
Age and fibrosis index for the prediction of hepatocellular carcinoma risk in patients with high hepatitis B virus DNA but normal alanine aminotransferase
Gyeol Seong, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
European Journal of Gastroenterology & Hepatology.2022; 34(1): 69.     CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach
Zhen Xun, Xiaobao Yao, Chenggong Zhu, Yuchen Ye, Songhang Wu, Tianbin Chen, Yongbin Zeng, Caorui Lin, Bin Yang, Qishui Ou, Can Liu
Materials Today Bio.2022; 15: 100302.     CrossRef
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B
An K Le, Hwai-I Yang, Ming-Lun Yeh, Mingjuan Jin, Huy N Trinh, Linda Henry, Anne Liu, Jian Q Zhang, Jiayi Li, Christopher Wong, Clifford Wong, Ramsey Cheung, Ming-Lung Yu, Mindie H Nguyen
The Journal of Infectious Diseases.2021; 223(1): 139.     CrossRef
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir
Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Yu Rim Lee, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Soo Young Park, Seung Up Kim
Journal of Viral Hepatitis.2021; 28(1): 95.     CrossRef
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B
Hye Won Lee, Young Eun Chon, Beom Kyung Kim, Terry Cheuk-Fung Yip, Yee-Kit Tse, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Sang Hoon Ahn
European Journal of Internal Medicine.2021; 84: 68.     CrossRef
Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach
Robério Amorim de Almeida Pondé
Molecular Biology Reports.2021; 48(1): 843.     CrossRef
No influence of hepatic steatosis on the 3‐year outcomes of patients with quiescent chronic hepatitis B
Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Viral Hepatitis.2021; 28(11): 1545.     CrossRef
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Korean Medical Science.2021;[Epub]     CrossRef
Breakthroughs and challenges in the management of pediatric viral hepatitis
Emanuele Nicastro, Lorenzo Norsa, Angelo Di Giorgio, Giuseppe Indolfi, Lorenzo D'Antiga
World Journal of Gastroenterology.2021; 27(20): 2474.     CrossRef
Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
Terry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clinical and Molecular Hepatology.2021; 27(2): 273.     CrossRef
Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus
Jing Zhou, Fa-Da Wang, Meng-Lan Wang, Ya-Chao Tao, Dong-Bo Wu, Yun-Jian Sheng, Gui-Bao Xiao, Xue-Bin Chen, Xin Chen, En-Qiang Chen
Frontiers in Medicine.2021;[Epub]     CrossRef
Guidelines for Prevention and Treatment of Chronic Hepatitis B
Guiqiang Wang, Zhongping Duan
Journal of Clinical and Translational Hepatology.2021; 000(000): 000.     CrossRef
Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients
Zhen Xun, Can Liu, Qing-Qing Yu, Jin-Piao Lin, Jin-Lan Huang, Ting-Wen Yang, Wen-Nan Wu, Song-Hang Wu, Qi-Shui Ou
Clinica Chimica Acta.2020; 502: 120.     CrossRef
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase
Hye Won Lee, Eun Hwa Kim, Jinae Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Clinical and Translational Gastroenterology.2020; 11(3): e00140.     CrossRef
Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients
Gi-Ae Kim, Seungbong Han, Gwang Hyeon Choi, Jonggi Choi, Young-Suk Lim
Alimentary Pharmacology & Therapeutics.2020; 51(11): 1169.     CrossRef
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase
Han Ah Lee, Hyun Woong Lee, In Hee Kim, Soo Young Park, Dong Hyun Sinn, Jung Hwan Yu, Yeon Seok Seo, Soon Ho Um, Jung Il Lee, Kwan Sik Lee, Chang Hun Lee, Won Young Tak, Young Oh Kweon, Wonseok Kang, Yong-Han Paik, Jin-Woo Lee, Sang Jun Suh, Young Kul Jun
Alimentary Pharmacology & Therapeutics.2020; 52(1): 196.     CrossRef
Editorial: risk assessment for chronic hepatitis B patients in the immune tolerant phase-both definition and selection matter
Yao-Chun Hsu, Yen-Tsung Huang
Alimentary Pharmacology & Therapeutics.2020; 52(1): 213.     CrossRef
Longitudinal Immune Phenotype Assessment and Serological Outcome in Foreign-born Children With Chronic Hepatitis B
Emanuele Nicastro, Benedetta Mangili, Vania Giacomet, Anna Rita Benincaso, Angelo Di Giorgio, Naire Sansotta, Annapaola Callegaro, Lorenzo D’Antiga
Journal of Pediatric Gastroenterology & Nutrition.2020; 71(3): 381.     CrossRef
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
Clinical and Molecular Hepatology.2020; 26(4): 411.     CrossRef
Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
Hye Won Lee, Seung Up Kim, Oidov Baatarkhuu, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Beom Kyung Kim
Scientific Reports.2019;[Epub]     CrossRef
Updated Treatment of Chronic Hepatitis B
Eileen L. Yoon, Hyung Joon Yim
The Korean Journal of Medicine.2019; 94(3): 252.     CrossRef
Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant
Pil Soo Sung, Dong Jun Park, Jung-Hee Kim, Ji Won Han, Eun Byul Lee, Gil Won Lee, Hee Chul Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Eui-Cheol Shin, Su-Hyung Park, Seung Kew Yoon
Frontiers in Immunology.2019;[Epub]     CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef
Are the Patients in the Immune Tolerant Phase of Chronic Hepatitis B far from Hepatocellular Carcinoma or Death?
Nae-Yun Heo
The Korean Journal of Gastroenterology.2019; 74(1): 66.     CrossRef
Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations
Won Hyeok Choe, Ki Jeong Kim, So Young Lee, Yu Min Choi, So Young Kwon, Jeong Han Kim, Bum Joon Kim
World Journal of Gastroenterology.2019; 25(33): 4985.     CrossRef
Phenotypes of Chronic Hepatitis B in Children From a Large North American Cohort
Kathleen B. Schwarz, Manuel Lombardero, Adrian M. Di Bisceglie, Karen F. Murray, Philip Rosenthal, Simon C. Ling, Yona Keich Cloonan, Norberto Rodriguez-Baez, Sarah Jane Schwarzenberg, Jay H. Hoofnagle, Jeffrey Teckman
Journal of Pediatric Gastroenterology & Nutrition.2019; 69(5): 588.     CrossRef
Natural History and Treatment Indications of Chronic Hepatitis B
Dong Hyun Sinn
The Korean Journal of Gastroenterology.2019; 74(5): 245.     CrossRef